Efficacy and Safety of Emodepside in Adults Infected With Strongyloidiasis Stercoralis
Status:
COMPLETED
Trial end date:
2024-09-21
Target enrollment:
Participant gender:
Summary
Efficacy, safety and pharmacokinetics of ascending dosages of emodepside and in comparison to ivermectin against Strongyloidiasis stercoralis in adults: randomized stage II seamless adaptive controlled trials
Phase:
PHASE2
Details
Lead Sponsor:
Swiss Tropical & Public Health Institute
Collaborator:
National Institute of Public Health, Vientiane, Laos